Quantitative analysis of antimicrobial effect kinetics in an in vitro dynamic model

被引:35
作者
FIRSOV, AA
CHERNYKH, VM
NAVASHIN, SM
机构
关键词
D O I
10.1128/AAC.34.7.1312
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Variants of the available methods for estimating antimicrobial effect kinetics in an in vitro dynamic model were analyzed. Two integral parameters characterizing antimicrobial effect duration (T(E)) and intensity (I(E)) are suggested to define and analyze the concentration-effect relationships in these models, irrespective of the method of recording. T(E) is defined by the time from the moment of antibiotic administration to the moment when the bacterial count again reaches its initial level. I(E) is defined by the area between the microbial growth curves in the presence and absence of an antibiotic. T(E) and I(E) were used to quantify the antimicrobial effects of sisomicin on Pseudomonas aeruginosa 58, Escherichia coli 93, and Klebsiella pneumoniae 5056, simulating the pharmacokinetic profiles of the drugs observed following intramuscular administration in therapeutic doses, including the variability of aminoglycoside concentrations in human blood.
引用
收藏
页码:1312 / 1317
页数:6
相关论文
共 24 条
[1]  
ALLERDERGER A, 1987, THERMOCHIM ACTA, V119, P113
[2]   IMPACT OF NETILMICIN REGIMENS ON THE ACTIVITIES OF CEFTAZIDIME-NETILMICIN COMBINATIONS AGAINST PSEUDOMONAS-AERUGINOSA IN AN INVITRO PHARMACOKINETIC MODEL [J].
BLASER, J ;
STONE, BB ;
GRONER, MC ;
ZINNER, SH .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1985, 28 (01) :64-68
[3]   A TEST AND CALIBRATION PROCESS FOR MICRO-CALORIMETERS USED AS THERMAL POWER METERS [J].
CHEN, AT ;
WADSO, I .
JOURNAL OF BIOCHEMICAL AND BIOPHYSICAL METHODS, 1982, 6 (04) :297-306
[4]  
CHERNYKH VM, 1985, ANTIBIOT MED BIOTEK, V30, P498
[5]  
DRUGEON HB, 1982, PATHOL BIOL, V30, P837
[6]  
FIRSOV AA, 1987, ANTIBIOT MED BIOTEK, V32, P685
[7]  
FIRSOV AA, 1989, ANTIBIOT KHIMIOTERAP, V34, P375
[8]   VALIDATION OF OPTIMAL AMPICILLIN SULBACTAM RATIO IN DOSAGE FORMS USING INVITRO DYNAMIC-MODEL [J].
FIRSOV, AA ;
NAZAROV, AD ;
CHERNYKH, VM ;
NAVASHIN, SM .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1988, 14 (15-17) :2425-2442
[9]  
FIRSOV AA, 1989, ADV SCI ENG, V17, P1
[10]  
GREENWOOD D, 1985, S SOC GEN MICROBIOL, V38, P323